Disease Domain | Count |
---|---|
Nervous System Diseases | 1 |
Infectious Diseases | 1 |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 2 |
Top 5 Target | Count |
---|---|
NOX(NADPH oxidase) | 1 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism NOX inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date20 Dec 2027 |
Sponsor / Collaborator ![]() [+2] |
Start Date30 May 2025 |
Sponsor / Collaborator |
Start Date01 Apr 2025 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Nitrochromene 5s(University of Aveiro) | Bacterial Infections More | Preclinical |
WO2023144742 ( NOX )Patent Mining | Nervous System Diseases More | Discovery |